The Ryman Cardiac Health And Monitoring Protocol In Older New Zealanders Study

An observational study to identify the prevalence of cardiovascular disease (CVD) and risk of new onset CVD within Ryman Healthcare NZ facilities

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12618000555257

Acronym

The CHAMPIONZ Study

Enrollment

236

Registered

2018-04-13

Start date

2019-03-22

Completion date

2030-12-31

Last updated

2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This 2-3 year project will support clinical research performed by the Christchurch Heart Institute (CHI) and will include a focus on identifying the prevalence of cardiovascular disease (CVD) and risk of new onset CVD within Ryman Healthcare NZ facilities and also assist healthcare staff current practices in CVD. This project will include lectures and information sessions to the Ryman medical and care staff as well as residents themselves. CHI research staff will partner with Ryman Healthcare staff to collect relevant clinical data from residents. Residents at selected Ryman Healthcare facilities will be invited to participate and consent will be obtained to collect clinical and medication data from a questionnaire and clinical and administrative records held by their general practitioner and the Ministry of Health. Among a representative sub group of approximately 1000 residents, consent would be obtained to attend a research clinic to perform measurements of body height, weight and composition, heart rate and rhythm, blood pressure and other relevant indices as well as collect blood samples to allow measurement of biomarkers. At the time of data collection, CHI staff will provide heart health education in partnership with the Heart Foundation.

Interventions

This 2-3 year project performed by the Christchurch Heart Institute (CHI) and will include a focus on identifying the prevalence of cardiovascular disease (CVD) and risk of new onset CVD within Ryman Healthcare New Zealand facilities and also assist healthcare staff current practices in CVD. This project will include lectures and information sessions to the Ryman medical and care staff as well as residents themselves.CHI research staff will partner with Ryman Healthcare staff to collect relevant clinical data from residents. Residents at all or selected Ryman Healthcare facilities will be invited to participate and consent will be obtained to collect clinical, medication, laboratory and mortality data from records. Among a representative sub group of approximately 1000 residents, consent would be obtained to collect blood samples to allow measurement of biomarkers as well as perform measurements of body height, weight and composition, heart rate and rhythm, blood pressure and other relevant indices.

Eligibility

Sex/Gender

All

Age

55 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Male or female Resident of a Ryman Healthcare facility

Exclusion criteria

Unwilling or unable to provide signed informed consent

Outcome results